4//SEC Filing
Grossman William 4
Accession 0001209191-21-042074
CIK 0001724521other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:48 PM ET
Size
9.9 KB
Accession
0001209191-21-042074
Insider Transaction Report
Form 4
Grossman William
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-06-16$24.77/sh−127$3,146→ 24,614 total - Sale
Common Stock
2021-06-17$23.68/sh−3,891$92,139→ 20,723 total - Sale
Common Stock
2021-06-16$24.13/sh−3,047$73,524→ 24,741 total
Footnotes (5)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.61 to $24.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 1,071 shares purchased on 5/28/2021 through the Company's Employee Stock Purchase Plan
- [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.63 to $24.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.395 to $24.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001730229
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:48 PM ET
- Size
- 9.9 KB